Estamos no ar no ! Saiba mais
ícone de BBC

Virtus Biotech Clinical Trials ETF

Nome Posição Valor negociado Ações
Variação
Variação na
participação
Goldman Sachs
1
Goldman Sachs
New York
US$ 1,9 mi – – –
LPL Financial
2
LPL Financial
California
US$ 940 mil +US$ 373 mil +19.252 +69%
Susquehanna International Group
3
Susquehanna International Group
Pennsylvania
US$ 463 mil -US$ 160 mil -8.255 -25%
Virtu KCG Holdings
4
Virtu KCG Holdings
New York
US$ 213 mil -US$ 986 mil -50.868 -82%
Ladenburg Thalmann Financial Services
5
Ladenburg Thalmann Financial Services
Florida
US$ 86 mil – – –
Royal Bank of Canada
6
Royal Bank of Canada
Ontario, Canada
US$ 37 mil +US$ 20,9 mil +1.080 +123%
Morgan Stanley
7
Morgan Stanley
New York
US$ 26 mil -US$ 7,76 mil -400 -23%
Creative Planning
8
Creative Planning
Kansas
US$ 16 mil – – –
UBS Group
9
UBS Group
Switzerland
US$ 9 mil -US$ 27,2 mil -1.405 -75%
MSI Financial Services
10
MSI Financial Services
Massachusetts
US$ 7 mil +US$ 1,55 mil +80 +27%
MassMutual Private Wealth & Trust
11
MassMutual Private Wealth & Trust
Connecticut
US$ 4,72 mil – – –
Tower Research Capital (TRC)
12
Tower Research Capital (TRC)
New York
US$ 3 mil -US$ 4,17 mil -215 -54%
Citadel Advisors
13
Citadel Advisors
Florida
– -US$ 945 mil -32.531 Encerrada
American International Group
14
American International Group
New York
– -US$ 7 mil -250 Encerrada
Next Financial Group
15
Next Financial Group
Texas
– -US$ 5 mil -204 Encerrada
AIA
16
Allegis Investment Advisors
Idaho
– -US$ 2 mil -85 Encerrada